Health-care Professionals' Knowledge and Perception of Adverse Drug Reaction Reporting and Pharmacovigilance in a Tertiary Care Teaching Hospital of Nepal
- PMID: 34024926
- PMCID: PMC8114297
- DOI: 10.1177/0018578719883796
Health-care Professionals' Knowledge and Perception of Adverse Drug Reaction Reporting and Pharmacovigilance in a Tertiary Care Teaching Hospital of Nepal
Abstract
Background: Underreporting of adverse drug reactions (ADRs) is common globally, and Nepal is not an exception to this. Health-care professionals (HCPs) play a vital role in reporting ADR during routine practice. Lack of knowledge and awareness about pharmacovigilance and reporting ADRs among HCPs may contribute to underreporting. Objective: The objective of this study was to evaluate the knowledge and perception of HCPs regarding ADR reporting and pharmacovigilance in a tertiary care teaching hospital in, Nepal. Methods: A descriptive cross-sectional study was conducted. A questionnaire was distributed to 215 HCPs (medical doctors, nurses, and pharmacists) between March and September 2018. Knowledge and perception regarding ADR reporting and pharmacovigilance were studied. Data were analyzed using IBM SPSS Statistics for Windows, Version 21.0 (IBM Corp, Armonk, New York). Results: The HCPs included 75 medical doctors, 126 nurses, and 14 pharmacists. Majority of the participants were female (67%), and the majority of participants were not aware of pharmacovigilance. Among the participants, pharmacists were found to have better knowledge regarding pharmacovigilance. However, other HCPs (doctors and nurses) strongly agreed about the necessity of having adequate knowledge about pharmacovigilance. Out of 215, 57.7% agreed that the important benefit of reporting ADR was to identify safe drugs and improve patient safety. The main reasons for not reporting were - ADR reporting was not widely promoted by relevant authorities (47%), followed by not knowing where and how to report ADR (34.9%). However, other HCPs (doctors and nurses) strongly agreed about the necessity of having adequate knowledge about pharmacovigilance. Conclusions: The knowledge of HCPs on ADR reporting and pharmacovigilance was poor. Despite a low knowledge of ADR reporting and pharmacovigilance among HCPs, there was a positive perception that ADR reporting is necessary and ADR monitoring system should be established in the hospital. This study also highlights a need for future intervention studies focusing on educating HCPs about ADR and pharmacovigilance.
Keywords: Nepal; adverse drug reaction reporting systems; health-care professionals’ knowledge; perception; pharmacovigilance.
© The Author(s) 2019.
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital.BMC Med Educ. 2020 Jun 3;20(1):179. doi: 10.1186/s12909-020-02084-7. BMC Med Educ. 2020. PMID: 32493307 Free PMC article.
-
Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.J Pharm Policy Pract. 2021 Jan 4;14(1):5. doi: 10.1186/s40545-020-00287-3. J Pharm Policy Pract. 2021. PMID: 33397478 Free PMC article.
-
Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.Drug Saf. 2016 Dec;39(12):1239-1250. doi: 10.1007/s40264-016-0465-2. Drug Saf. 2016. PMID: 27743333
-
Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.Curr Med Res Opin. 2022 Jan;38(1):145-154. doi: 10.1080/03007995.2021.1997287. Epub 2021 Nov 3. Curr Med Res Opin. 2022. PMID: 34694167
-
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Health Technol Assess. 2011. PMID: 21545758 Review.
Cited by
-
Pharmacovigilance Practices by Healthcare Providers in Oncology: A Cross-Sectional Study.Pharmaceuticals (Basel). 2024 May 26;17(6):683. doi: 10.3390/ph17060683. Pharmaceuticals (Basel). 2024. PMID: 38931351 Free PMC article.
-
Educational intervention impact assessment on pharmacovigilance knowledge, attitude and practice among hospital pharmacy practitioners in Dubai.J Pharm Policy Pract. 2025 May 30;18(1):2509223. doi: 10.1080/20523211.2025.2509223. eCollection 2025. J Pharm Policy Pract. 2025. PMID: 40458208 Free PMC article.
-
COVID-19 vaccination pharmacovigilance in Khojaly district, Uzbekistan: an epidemiological evaluation.Front Public Health. 2025 Jul 2;13:1520821. doi: 10.3389/fpubh.2025.1520821. eCollection 2025. Front Public Health. 2025. PMID: 40672927 Free PMC article.
-
Pattern of Adverse Drug Reactions Associated with the Use of Anticancer Drugs in an Oncology-Based Hospital of Nepal.JMA J. 2022 Oct 17;5(4):416-426. doi: 10.31662/jmaj.2021-0015. Epub 2022 Sep 26. JMA J. 2022. PMID: 36407064 Free PMC article.
-
Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital.BMC Med Educ. 2020 Jun 3;20(1):179. doi: 10.1186/s12909-020-02084-7. BMC Med Educ. 2020. PMID: 32493307 Free PMC article.
References
-
- World Health Organization. Requirements for Adverse Reaction Reporting. Geneva, Switzerland: World Health Organization; 1975.
-
- World Health Organization. The safety of medicines in public health programmes: pharmacovigilance, an essential tool. 2006. https://www.who.int/medicines/areas/quality_safety/safety_efficacy/Pharm.... Accessed August 18, 2019.
-
- Buajordet I, Ebbesen J, Erikssen J, Brors O, Hilberg T. Fatal adverse drug events: the paradox of drug treatment. J Intern Med. 2001;250(4):327-341. - PubMed
-
- Ebbesen J, Buajordet I, Erikssen J, et al.. Drug-related deaths in a department of internal medicine. Arch Intern Med. 2001;161(19):2317-2323. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials